Diabetic retinopathy: mechanisms, and upcoming biomarkers
Journal Title: Central Asian Journal of Medical and Pharmaceutical Sciences Innovation - Year 2021, Vol 1, Issue 3
Abstract
Obesity is an important issue that affects many people all over the world. This condition contributes to an increase in prevalence of type 2 diabetes. Furthermore, an unexplained rise in the number of type 1 diabetes has occurred. However, due to the recent developments in the field of diabetes care, it is still a significant cause of visual impairment in elderly. Diabetic retinopathy (D.R) is a critical issue for many people with diabetes. Various risk factors have been identified for diabetic retinopathy, including; blood pressure, weight, serum levels of lipid, and glycemic status. This pathology could be detected and treated by regular screening procedures, especially for late-stage of retinopathy. Angiogenesis inhibition is considered a modern therapy using intraocular steroids and intravitreal application of vascular endothelial growth factor (VEGF) treatments. Unfortunately, a majority of patients with diabetic retinopathy are unable to benefit from accessible medications. Diabetic retinopathy is more severe which require modern treatments. Discovering the molecular markers can increase the speed of research on D.R. Thus, there is a significant increase in diabetes and the urgent need for accurate detection of following diabetic retinopathy. Pathology can help in the detection of retinopathy in developing treatments and preventative methods for diabetic vision loss. This article discussed many important biomarker discoveries in these pathologic conditions.
Authors and Affiliations
Muhammed Furkan Ercisli; Toktam Sadat Tavabe Ghavami; Farzane Alaei; Fatemeh Pashizeh
Keywords
Related Articles
- EP ID EP714355
- DOI 10.22034/CAJMPSI.2021.03.03
- Views 69
- Downloads 0
Genetic and epigenetic collaboration in Parkinson’s disease
Parkinson's disease (PD) is a common neurodegenerative syndrome directly related to age development. This pathologic condition presents in many types of forms. Some efforts applied to understand PD development include re...
Alzheimer's disease as a neurodegenerative disorder and the apolipoprotein E gene as its genetic biomarker
Alzheimer's disease (AD) is a progressive brain disorder that slowly destroys memory and thinking and functional skills. Alzheimer's disease is classified into two familial and sporadic types. Alzheimer's disease is also...
Investigation of the effect of pd1.1, pd1.5, and pd1.9 mutations on pd1 gene function with a system biology approach
Programmed cell death 1 (pd1) is an immune-inhibitory receptor that is expressesd in activated T cells. This gene may play a role in the inhibition of actual anti- microbial and anti-tumor immunity. In human, this gene i...
Role of ESR1 PvuII T/C variant in female reproductive process: A review
Estrogen hormone is involved in the process of reproduction by banding to estrogen receptors (ERs). The findings of previous studies showed the association of a common variant, PvuII T/C (rs 2234693), in ESR1 gene with d...
The role of hyperuricemia in the pathophysiology of preeclampsia
Preeclampsia (PE) is a human pregnancy disorder that begins with high blood pressure. This disorder occurs after 20 weeks of pregnancy and is defined by the high pressure of blood and proteinuria symptoms. Also, PE is re...